Insider Sale: Rubric Capital, David Rosen Reduce COLL Position by 25,000 Shares
Rhea-AI Filing Summary
Rubric Capital Management LP and David Rosen reported the sale of 25,000 shares of Collegium Pharmaceutical, Inc. (COLL) on 08/13/2025 at a weighted average price of $37.85 per share, with transaction prices ranging from $37.71 to $38.10. After the sale, the Reporting Persons collectively beneficially own 3,132,743 shares indirectly through funds/accounts managed by Rubric Capital.
The Form 4 clarifies Rubric Capital is the investment adviser to the reporting vehicles and Mr. Rosen is the managing member of the general partner; the filing disclaims beneficial ownership except to the extent of any pecuniary interest. The Reporting Persons offer to provide detailed per-price sale breakdowns to the issuer or SEC staff upon request.
Positive
- Complete and transparent disclosure of the sale including weighted average price and price range
- Large remaining indirect stake of 3,132,743 shares indicates continued substantial ownership
Negative
- Insider-affiliated sale of 25,000 shares on 08/13/2025, which may be viewed negatively by some investors
Insights
TL;DR: Director-affiliated adviser sold a small portion of a large indirect stake; overall ownership remains substantial and disclosure is complete.
The 25,000-share disposition represents a modest reduction relative to the 3.13 million shares reported as beneficially owned, suggesting the sale is not a material change to ownership structure. The filing is properly executed by both Rubric Capital and David Rosen and includes the weighted average price and price range, which supports transparency for investors and regulators. The offer to provide per-price details on request aligns with best practices for disclosure. No derivatives or additional transactions are reported.
TL;DR: Transaction disclosed correctly under Section 16; maintains regulatory compliance while signaling routine portfolio activity.
The Form 4 attributes the shares to Rubric Vehicles with indirect ownership through the adviser and general partner structure, and includes the customary disclaimer of beneficial ownership limits. The sale was executed in multiple tranches across a narrow price band, which is documented as a weighted average. From a governance perspective, the dual signatures and explicit explanation reduce ambiguity about control and reporting responsibility. The filing contains no indication of policy-driven plan sales or derivates activity.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, par value $0.001 per share | 25,000 | $37.85 | $946K |
Footnotes (1)
- This Form 4 is filed by Rubric Capital Management LP ("Rubric Capital") and Mr. David Rosen, with respect to the securities held by certain funds and/or accounts (collectively, the "Rubric Vehicles"). Rubric Capital serves as the investment adviser to the Rubric Vehicles. Mr. David Rosen serves as the Managing Member of Rubric Capital Management GP, LLC, the general partner of Rubric Capital. The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein, if any. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.71 to $38.10, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
